Invivyd, Inc. (IVVD) Form 10-K Annual Reports
Invivyd, Inc. (IVVD) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: IVVD
CIK: 1832038
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerMark DeCost
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-29 | 2026-09-29 | 8-K | 0001193125-26-406007 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0001193125-26-380337 | View SEC Doc Filr Page |
| 3 | 2026-09-02 | 2026-08-30 | 3 | 0001193125-26-380335 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-30 | 4 | 0001193125-26-378862 | View SEC Doc Filr Page |
| 8-K | 2026-09-01 | 2026-08-30 | 8-K | 0001193125-26-377493 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-15 | 4 | 0001193125-26-355915 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-15 | 4 | 0001193125-26-355914 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-15 | 4 | 0001193125-26-355913 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-15 | 4 | 0001193125-26-355912 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-15 | 4 | 0001193125-26-355911 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001193125-26-354036 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001193125-26-354034 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001193125-26-354033 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001193125-26-354032 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001193125-26-354030 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-352642 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000921895-26-002171 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-349215 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001193125-26-349193 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-07-31 | 4 | 0001193125-26-332844 | View SEC Doc Filr Page |
| 3 | 2026-08-04 | 2026-07-31 | 3 | 0001193125-26-332833 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-28 | — | SCHEDULE 13G Filing | 0002012383-26-002467 | View SEC Doc Filr Page |
| 8-K | 2026-07-24 | 2026-07-23 | 8-K | 0001193125-26-316066 | View SEC Doc Filr Page |
| 8-K | 2026-07-06 | 2026-07-06 | 8-K | 0001193125-26-295539 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | 4 | 0001193125-26-234666 | View SEC Doc Filr Page |